Business
Currency:USD
2024/Q2
Stock NameRevenueRatio
Diagnostic solutions184.68M37.21%
Sample technologies163.73M32.99%
Polymerase Chain Reaction (PCR) / Nucleic acid amplification76.07M15.33%
Genomics / Next-Generation Sequencing (NGS)58.26M11.74%
Other13.61M2.74%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States935.28M47.59%
Europe, Middle East and Africa604.27M30.75%
Asia Pacific, Japan and Rest of World320.68M16.32%
Other Americas84.77M4.31%
Netherlands20.3M1.03%